You're one step closer to unlocking our suite of comprehensive and robust tools.
Fill out the form so we can connect you to the right person.
If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.
Frazier Healthcare Partners pulls in over $617M for latest life sciences fund
Street Talk Episode 56 - Latest bank MOE shows even the strong need scale to thrive
South State CenterState MOE Shows Even The Strong Need Scale To Thrive
Talking Bank Stocks, Playing The M&A Trade With Longtime Investor
Report: Kashkari Says Fed In Holding Pattern But Rate Cut Still Possible
Frazier Healthcare Partners, or Frazier Management LLC, raised over $617 million for Frazier Life Sciences X LP.
The oversubscribed fund will mainly target therapeutics-focused companies that develop and commercialize biopharmaceuticals.
It will invest in company creation, early-stage venture and late-stage private or public opportunities, with two-thirds of its capital to be allocated in seed and series A financing rounds.